Engraftment in 86 patients with lymphoid malignancy after autologous marrow transplantation
R.S. Hill(Fred Hutch Cancer Center), R. Livingston(Fred Hutch Cancer Center), Keith M. Sullivan(Duke Medical Center), K Doney(University of Washington Medical Center), Simona Sica(San Antonio College), Jack W. Singer(NorthShore University HealthSystem), R. P. Whiterspoon(Fred Hutch Cancer Center), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), R A Clift(Fred Hutch Cancer Center), Patricia Stewart(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), C. Dean Buckner(University of Washington), Patrizio Mazza(Ospedale SS. Annunziata), D. B. Amos(Florida College), B.J. Still, JE Sanders(Fred Hutch Cancer Center), R. J. Berenson(Fred Hutch Cancer Center), F. R. Appelbaum, Philip Matin(Fred Hutch Cancer Center)
Bone Marrow Transplantation
January 1, 1989
Cited by 37
Related Papers
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k